189 related articles for article (PubMed ID: 35499760)
1. Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma.
Zhang B; Peng H; Zhou M; Bao L; Wang C; Cai F; Zhang H; Wang JE; Niu Y; Chen Y; Wang Y; Hatanpaa KJ; Copland JA; DeBerardinis RJ; Wang Y; Luo W
Cancer Res; 2022 Jul; 82(13):2388-2402. PubMed ID: 35499760
[TBL] [Abstract][Full Text] [Related]
2. Driving with Both Feet: Supplementing AKG While Inhibiting BCAT1 Leads to Synthetic Lethality in GBM.
Meurs N; Nagrath D
Cancer Res; 2022 Jul; 82(13):2354-2356. PubMed ID: 35788291
[TBL] [Abstract][Full Text] [Related]
3. Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.
Cho HR; Hong B; Kim H; Park CK; Park SH; Park S; Choi SH
Oncotarget; 2016 Oct; 7(43):69606-69615. PubMed ID: 27626306
[TBL] [Abstract][Full Text] [Related]
4. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
Raffel S; Falcone M; Kneisel N; Hansson J; Wang W; Lutz C; Bullinger L; Poschet G; Nonnenmacher Y; Barnert A; Bahr C; Zeisberger P; Przybylla A; Sohn M; Tönjes M; Erez A; Adler L; Jensen P; Scholl C; Fröhling S; Cocciardi S; Wuchter P; Thiede C; Flörcken A; Westermann J; Ehninger G; Lichter P; Hiller K; Hell R; Herrmann C; Ho AD; Krijgsveld J; Radlwimmer B; Trumpp A
Nature; 2017 Nov; 551(7680):384-388. PubMed ID: 29144447
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
[TBL] [Abstract][Full Text] [Related]
6. BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.
Cho HR; Jeon H; Park CK; Park SH; Kang KM; Choi SH
Sci Rep; 2017 Dec; 7(1):17740. PubMed ID: 29255149
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin Can Suppress Cell Proliferation Independent of the Cytosolic Branched-Chain Amino Acid Transferase 1 (BCAT1).
Grankvist N; Lagerborg KA; Jain M; Nilsson R
Biochemistry; 2018 Dec; 57(49):6762-6766. PubMed ID: 30427175
[TBL] [Abstract][Full Text] [Related]
8. Impaired expression of BCAT1 relates to muscle atrophy of mouse model of sarcopenia.
Ouyang H; Gao X; Zhang J
BMC Musculoskelet Disord; 2022 May; 23(1):450. PubMed ID: 35562710
[TBL] [Abstract][Full Text] [Related]
9. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.
Tönjes M; Barbus S; Park YJ; Wang W; Schlotter M; Lindroth AM; Pleier SV; Bai AHC; Karra D; Piro RM; Felsberg J; Addington A; Lemke D; Weibrecht I; Hovestadt V; Rolli CG; Campos B; Turcan S; Sturm D; Witt H; Chan TA; Herold-Mende C; Kemkemer R; König R; Schmidt K; Hull WE; Pfister SM; Jugold M; Hutson SM; Plass C; Okun JG; Reifenberger G; Lichter P; Radlwimmer B
Nat Med; 2013 Jul; 19(7):901-908. PubMed ID: 23793099
[TBL] [Abstract][Full Text] [Related]
10. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
Stichel D; Ebrahimi A; Reuss D; Schrimpf D; Ono T; Shirahata M; Reifenberger G; Weller M; Hänggi D; Wick W; Herold-Mende C; Westphal M; Brandner S; Pfister SM; Capper D; Sahm F; von Deimling A
Acta Neuropathol; 2018 Nov; 136(5):793-803. PubMed ID: 30187121
[TBL] [Abstract][Full Text] [Related]
11. Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression.
Boskovic P; Wilke N; Man KH; Lichter P; Francois L; Radlwimmer B
Neuro Oncol; 2024 Feb; 26(2):251-265. PubMed ID: 37769206
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA VPS18 Promotes Glioblastoma Progression by Regulating miR-1229-3p/BCAT1 Axis.
Huang Q; Li W; Huang Y; Chen Q; Wei W
Neurotox Res; 2022 Oct; 40(5):1138-1151. PubMed ID: 35776379
[TBL] [Abstract][Full Text] [Related]
13. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma.
Chaumeil MM; Larson PE; Woods SM; Cai L; Eriksson P; Robinson AE; Lupo JM; Vigneron DB; Nelson SJ; Pieper RO; Phillips JJ; Ronen SM
Cancer Res; 2014 Aug; 74(16):4247-57. PubMed ID: 24876103
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
Zhang L; Han J
Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination degradation of BCAT1 promotes GBM progression.
Wang W; Li Y; Tang L; Shi Y; Li W; Zou L; Zhang L; Cheng Y; Yuan Z; Zhu F; Duan Q
Cancer Lett; 2024 Jun; 591():216849. PubMed ID: 38621458
[TBL] [Abstract][Full Text] [Related]
16. The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtype.
Fala M; Ros S; Sawle A; Rao JU; Tsyben A; Tronci L; Frezza C; Mair R; Brindle KM
Neurooncol Adv; 2023; 5(1):vdad120. PubMed ID: 37885806
[TBL] [Abstract][Full Text] [Related]
17. Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.
Liu EM; Shi ZF; Li KK; Malta TM; Chung NY; Chen H; Chan JY; Poon MF; Kwan JS; Chan DT; Noushmehr H; Mao Y; Ng HK
Brain Pathol; 2022 Nov; 32(6):e13107. PubMed ID: 35815721
[TBL] [Abstract][Full Text] [Related]
18. BCAT1 promotes osteoclast maturation by regulating branched-chain amino acid metabolism.
Go M; Shin E; Jang SY; Nam M; Hwang GS; Lee SY
Exp Mol Med; 2022 Jun; 54(6):825-833. PubMed ID: 35760874
[TBL] [Abstract][Full Text] [Related]
19. The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.
Thewes V; Simon R; Hlevnjak M; Schlotter M; Schroeter P; Schmidt K; Wu Y; Anzeneder T; Wang W; Windisch P; Kirchgäßner M; Melling N; Kneisel N; Büttner R; Deuschle U; Sinn HP; Schneeweiss A; Heck S; Kaulfuss S; Hess-Stumpp H; Okun JG; Sauter G; Lykkesfeldt AE; Zapatka M; Radlwimmer B; Lichter P; Tönjes M
Oncogene; 2017 Jul; 36(29):4124-4134. PubMed ID: 28319069
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Translocation of LDHA Promotes the Catabolism of BCAAs to Sustain GBM Cell Proliferation through the TxN Antioxidant Pathway.
Li Z; Gu Z; Wang L; Guan Y; Lyu Y; Zhang J; Wang Y; Wang X; Xiong J; Liu Y
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
